Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis

Diseases of the Colon and Rectum

Volumn 41, Issue 12, 1998, Pages 1543-1549

  Broome U ^a   Hultcrantz, R ^a   Lefvert, A K ^a   Yi, Q ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytokines; T cells; Th0, Th1; Th2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; COLONOSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HUMAN; HUMAN TISSUE; LAMINA PROPRIA; MALE; MONONUCLEAR CELL; PRIMARY SCLEROSING CHOLANGITIS; ULCERATIVE COLITIS;

EID: 0031701716     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02237304     Document Type: Article

References (39)

1. Olsson R, Danielsson A, Järnerot G, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991;100:1319-23.
2. Schrumpf E, Fausa O, Kolmannskog F, ElgjoK, Ritland S, Gjone E. Sclerosing cholangitis in ulcerative colitis. A follow-up study. Scand J Gastroenterol 1982;17:33-9.
3. Sartor RB, Bender DE, Allen J. B, et al. Chronic extraintestinal inflammation is T lymphocyte dependent. Gastroenterology 1993;104:775A.
4. Emmerich J, Seyfarth M, Fleig WE. Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody. Lancet 1991;1:570-1.
5. Lichtiger S, Present DH. Cyclosporin in treatment of severe active ulcerative colitis. Lancet 1990;336:16-9.
6. Whiteside TL, Lasky S, Si L, Van Thiel DH. Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology 1985;5:468-74.
7. Broomé U, Hultcrantz R, Scheynius A. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis. Scand J Gastroenterol 1993;28:126-30.
8. Lindor KD, Wiesner RH, La Russo NF, Homburger HA. Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis. Hepatology 1987;7:884-8.
9. Mieli-Vergani G, Lobo-Yeo A, McFarlane B M, Mowat AP, Vergani D. Different immune mechanisms leading to autoimmunity in primary sderosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology 1989;9:198-203.
10. Lindor KD, Wiesner RH, Katzmann JA, LaRusso NF, Beaver SJ. Lymphocyte subsets in primary sclerosing cholangitis. Dig Dis Sci 1987;32:720-5.
11. James SP. The role of lymphokines and cytokines in mucosal immune function. Curr Opin Gastroenterol 1991;7:437-45.
12. Broomé U, Glaumann H, Hultcrantz R, Forsum U. Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis. Scand J Gastroenterol 1990;25:54-8.
13. Selby WS, Janossy G, Mason DY, Jewell DP. Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol 1983;81:301-5.
14. Mosmann TR, Coffman RL. Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145-73.
15. Del Prete GF, De Carli M, Ricci M, Romagnani S. Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: the help of Th1 clones is limited by their cytolytic capacity. J Exp Med 1991;174:809-13.
16. Wierenga EA., Snoeck M, de Groot C, et al. Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990;144: 4651-6.
17. Broomé U, Löfberg R, Lundqvist K, Veress B. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis Colon Rectum 1995;38:1301-5.
18. Lundqvist K, Broomé U. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Dis Colon Rectum 1997;40:451-6.
19. Perdigoto R, Wiesner R, LaRusso N, Dozois, R. Inflammatory bowel disease associated with primary sclerosing cholangitis: incidence, severity and relationship to liver disease. Gastroenterology 1991;100:A238.
20. Chapman RW, Arborgh BA, Rhodes JM, et al. Primary sclerosing cholangitis; a review of its clinical features, cholangiography and hepatic histology. Gut 1980;21: 870-7.
21. Evans JG, Acheson ED. An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. Gut 1965;6:311-24.
22. Yi Q, Åhlberg R, Pirskanen R, Lefvert AK. Acetylcholine receptor-reactive T cells in myasthenia gravis: Evidence for the involvement of different subpopulations of T helper cells. J Neuroimmunol 1994;50:177-86.
23. Powrie F, Leach MW, Mauze S, Menon S, Barcomb Caddle L, Coffman RL. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice recon-stituted with CD45RBhi CD4+ T cells. Immunity 1994; 1:553-62.
24. Schreiber RA, Kleinman RE, Barksdale EM, Maganaro TF, Donahoe PK. Rejection of murine congeneic bile ducts: a model for immune-medited bile duct disease. Gastroenterology 1992;102:924-30.
25. Fukushima K, West GA, Klein JS, Levine AD, Fiochi C. Opposite modulatory activity of IL-10 and IL-4 in lamina propria mononuclear cells (LPMC) is stimulus-dependent. Gastroenterology 1994;104:A702.
26. Fiocchi C, Hilfiker ML, Youngman KR, Doerder NC, Finke JH. Interleukin 2 activity of human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology 1984;86:734-42.
27. Kusugami K, Matsuura T, West GA, Youngman KR, Rachmilewitz D, Fiocchi C. Loss of interleukin-2 producing intestinal CD4+ cells in inflammatory bowel disease. Gastroenterology 1991;101:1594-1605.
28. Sadlack B, Mertz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Gastroenterology 1993; 75:253-61.
29. Chomarat P, Banchereau J. An update on interleukin-4 and its receptor. Eur Cytokine Netw 1997;8:333-44.
30. Fiocchi C, Fukushima K, Strong SA, Ina K. Pitfalls in cytokine analysis in inflammatory bowel disease. Aliment Pharmacol Ther 1996;10(Suppl 2):63-9.
31. Ebert EC. Proliferative responses of human intraepithelial lymphocytes to various T-cell stimuli. Gastroenterology 1989;97:1372-81.
32. Kabilan L, Andersson G, Lolli F, Ekre H-P, Olsson T, Troye-Blomberg M. Detection of intracellular expression and secretion of interferon-7 at the single-cell level after activation of human T-cells with tetanus toxoid in vitro. Eur J Immunol 1990;20:1085-9.
33. Czerkinsky C, Andersson G, Ekre HP, Nilsson LÅ, Klareskog L, Ouchterlony Ö. Reverse ELISPOT assay for clonal analysis of cytokine production, enumeration of gamma-interferon-secreting cells. J Immunol Methods 1988;110:29-36.
34. Murray JS, Madri J, Pasqualini T, Bottomly K. Functional CD4 T cell subset interplay in an intact immune system. J Immunol 1993;150:4270-6.
35. Zetterquist H, Broomé U, Einarsson K, Olerup O. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis. Gut 1992;33:942-6.
36. Olerup O, Olsson R, Hultcrantz R, Broomé U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1995;108:870-8.
37. Broomé U, Glaumann H, Hultcrantz R. Liver histology and follow-up of 68 patients with ulcerative colitis and normal liver function tests. Gut 1990;31:468-72.
38. Broomé U, Glaumann H, Hellers G, Sörstad J, Nilsson B, Hultcrantz R. Liver disease in ulcerative colitis. An epidemiological and follow-up study in the county of Stockholm. Gut 1994;35:84-9.
39. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T-cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34-8.